Clinical Trial Update: Early Inhaled Nitric Oxide for Respiratory Failure in Newborns [Phase 3]

View source ↗

Summary

Phase 3 trial investigating early inhaled nitric oxide for respiratory failure in newborns was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Newborn
• Persistent Fetal Circulation Syndrome
• Pneumonia Aspiration
• Pulmonary Hypertension Neonatal
• Respiratory Distress Syndrome Newborn
• Respiratory Insufficiency

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Hypertension, Pulmonary | Phase 3 | Status: TERMINATED